Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

127.78
Delayed Data
As of Apr 28
 +0.87 / +0.69%
Today’s Change
109.12
Today|||52-Week Range
157.02
+4.44%
Year-to-Date

Today’s Trading

Previous close126.91
Today’s open127.67
Day’s range125.64 - 128.74
Volume3,167,438
Average volume (3 months)2,216,722
Market cap$28.7B
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+162.69%
Earnings growth (this year)+14.58%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+21.11%
P/E ratio72.6
Price/Sales9.22
Price/Book3.29

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+0.88+0.75%
ZTSZoetis Inc-0.35-0.62%
BAXBaxter International...+0.26+0.47%
INCYIncyte Corp+0.11+0.09%
Data as of 4:14pm ET, 04/28/2017

Financials

Last reporting dateApril 27, 2017
EPS forecast (this quarter)$1.24
Annual revenue (last year)$3.0B
Annual profit (last year)$399.0M
Net profit margin13.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts